The combination of deep learning and pseudo-MS image improves the applicability of metabolomics to congenital heart defect prenatal screening
Author:
Sun BoruiORCID,
Fang YiweiORCID,
Yang Hui,
Meng Fan,
He Chao,
Zhao Yun,
Zhao Kai,
Zhang Huiping
Reference29 articles.
1. Congenital heart disease: causes, diagnosis, symptoms, and treatments;Sun;Cell Biochem. Biophys.,2015
2. Congenital heart disease prevalence: what does the future hold?;Frogoudaki;Eur J Prev Cardiol,2023
3. Current status of screening, diagnosis, and treatment of neonatal congenital heart disease in China;Ma;World J Pediatr,2018
4. Geographical and socioeconomic factors influence the birth prevalence of congenital heart disease: a population-based cross-sectional study in Eastern China;Pan;Curr. Probl. Cardiol.,2022
5. Incidence, distribution, disease spectrum, and genetic deficits of congenital heart defects in China: implementation of prenatal ultrasound screening identified 18,171 affected fetuses from 2,452,249 pregnancies;Chen;Cell Biosci.,2023